Advertisement
Screener

Ovid Therapeutics Inc. (OVID) Net Margin

Ovid Therapeutics Inc. (OVID) Net Margin

  • 2026-06-30: Net Margin -2047.61%.
  • 2025-12-31: Net Margin 1345.82%.
  • 2025-09-30: Net Margin -9210.61%.
  • 2025-06-30: Net Margin -74.68%.

Complete source-backed net margin history.

Available history
2020-09-30 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-2047.61%
2025-12-311345.82%
2025-09-30-9210.61%
2025-06-30-74.68%
2025-03-31-7873.08%
2024-12-31-12175.00%
2024-09-30-8095.95%
2024-06-305042.01%
2024-03-31-7901.35%
2023-12-31-10790.14%
2023-09-30-10323.85%
2023-06-30-16544.00%
2023-03-31-20236.36%
2022-12-31-24859.09%
2022-09-30-107798.33%
2022-03-31-1114.46%
2021-03-3184.46%
2020-12-31-386.27%
2020-09-30-237.56%

Annual Net Margin

DateNet Margin
2025-12-31-240.13%
2024-12-31-4670.14%
2023-12-31-13351.79%
2022-12-31-3604.66%
2021-12-3158.95%
2020-12-31-642.26%

Similar stocks

Stock NameCountryMarket CapPE Ratio
ASSEMBLY BIOSCIENCES, INC. (ASMB)United States$0.481B-13,053.96
CAPRICOR THERAPEUTICS, INC. (CAPR)United States$0.499B-10.81
PUMA BIOTECHNOLOGY, INC. (PBYI)United States$0.507B15.53
ARVINAS, INC. (ARVN)United States$0.510B58.38
MapLight Therapeutics, Inc. (MPLT)United States$0.459B-7.10
Evolus, Inc. (EOLS)United States$0.519B-13.32
CRESCENT BIOPHARMA, INC. (CBIO)United States$0.529B-5.20
Quoin Pharmaceuticals Ltd. (QNRX)$0.443B-17.85
CYPHERPUNK TECHNOLOGIES INC. (CYPH)United States$0.438B-75.63
Indaptus Therapeutics, Inc. (INDP)United States$0.537B